Last update :
03/05/2024
Antimuscarinic   Atropine sulfate  
Injection
Aerosol Eye-drops Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Atropen United States of America
Atropi S Italy
Atropin Denmark, Finland, Iceland, Norway, Sweden, Turkey, Venezuela
Atropina Argentina, Colombia, Ecuador, Italy, Portugal, Spain, Venezuela
Atropina sulfato Chile, Colombia, Ecuador, Italy, Peru
Atropine Australia, Canada, France, Great Britain, Greece, Ireland, Morocco, New Zealand, Saudi Arabia, Tunisia
Atropine sulf ES Saudi Arabia
Atropine sulphate Egypt, Ireland, Malaysia, Saudi Arabia
Atropinesulfate Belgium, Canada, Egypt, Luxembourg, Malaysia, New Zealand, United Arab Emirates, United States of America
Atropinsulfat Austria, Germany, Luxembourg, Switzerland
Atropinum sulfuricum Austria, Germany, Hungary, Poland, Switzerland
Atropion Brazil
Atropisa Brazil, Chile, Ecuador, Mexico
Dicatro Iran
Endatropina Argentina
Klonatropina Argentina
Minijet Atropine Great Britain
Stellatropine Belgium
Sulfat de atropina Romania
Sulfato de atropina Argentina, Ecuador
Stability of mixtures   Injection   Stability of mixtures : Atropine sulfate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,4 & 1 mg/ml
Injection   Atropine sulfate   
Injection   Tirofiban 50 µg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass Glucose 5% 0,19 mg/ml
Injection   Atropine sulfate   
Injection   Palonosetron hydrochloride 25 µg/ml
25°C
4 Hour
Light 2279
Level of evidence A+
Polypropylene Sodium chloride 0,9% 0,133 mg/ml
Injection   Atropine sulfate   
Injection   Ondansetron hydrochloride 1,33 mg/ml
23°C
24 Hour
Light 815
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,133 mg/ml
Injection   Atropine sulfate   
Injection   Ondansetron hydrochloride 1,33 mg/ml
4°C
24 Hour
Protect from light 815
Level of evidence C+

  Mentions Légales